Three Good Things (3GT) - Intervention for Transitional Care Patients

Sponsor

Mayo Clinic (Other)

Overall Status

Recruiting

CT.gov ID

NCT04970641

Collaborator

(none)

Enrollment

Location

Arms

Anticipated Duration (Months)

2.2

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Researchers are doing this research study to learn how the Three Good Things (3GT) Positive Psychology journaling activity affects symptoms of stress, depression, resilience, and happiness.

Condition or Disease	Intervention/Treatment	Phase
Positive Thinking Psychology, Positive Resilience, Psychological	Behavioral: Three Good Things (3GT) Positive Psychology journaling activity	N/A

Detailed Description

The purpose of this study is to measure, rank and categorize the subject sample of depression, stress, resilience and happiness scores using quantitative surveys. This research aims to learn how a Three Good Things (3GT) journaling activity affects a subject's symptoms of stress, depression, resilience and happiness. The data will allow the project team to gain an in-depth understanding of the impact of the use of resilience strategies from a hospitalized patient's perspective. The project aims to review if there is a correlation between stress, depression, resiliency, and happiness scores to the use of Positive Psychology.

Study Design

Study Type:

Interventional

Anticipated Enrollment :

40 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

None (Open Label)

Primary Purpose:

Supportive Care

Official Title:

Three Good Things (3GT) - Intervention for Transitional Care Patients at the Mayo Clinic Bloomer Critical Access Hospital

Actual Study Start Date :

Sep 30, 2021

Anticipated Primary Completion Date :

Dec 31, 2022

Anticipated Study Completion Date :

Mar 31, 2023

Arms and Interventions

Arm	Intervention/Treatment
Experimental: 3GT journaling group Subjects will participate in the Three Good Things (3GT) Positive Psychology journaling activity daily for six weeks.	Behavioral: Three Good Things (3GT) Positive Psychology journaling activity Evening journaling activity each day to reflect on three good things that the subject has noticed about their day's events.
No Intervention: Non-journaling group Subjects will not participate in the evening journal activity.

Arm

Intervention/Treatment

Experimental: 3GT journaling group

Subjects will participate in the Three Good Things (3GT) Positive Psychology journaling activity daily for six weeks.

Behavioral: Three Good Things (3GT) Positive Psychology journaling activity

Evening journaling activity each day to reflect on three good things that the subject has noticed about their day's events.

No Intervention: Non-journaling group

Subjects will not participate in the evening journal activity.

Outcome Measures

Primary Outcome Measures

Perceived Stress [Baseline, 6 weeks]
Change in subject perceived stress measured using the self-reported perceived stress scale (PSS). A 10-item questionnaire assessing individuals' appraisal of stress using a scale of 0=never, 4=very often.

Secondary Outcome Measures

Subjective Depression [Baseline, 6 weeks]
Change in subject depression measured using the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R-10).
Subjective Happiness [Baseline, 6 weeks]
Change in subject happiness measured using the self-reported subjective happiness scale (SHS). A 4-item scale of global subjective happiness. Two items ask respondents to characterize themselves using both absolute ratings and ratings relative to peers, whereas the other two items offer brief descriptions of happy and unhappy individuals and ask respondents the extent to which each characterization describes them.
Subjective Resilience [Baseline, 6 weeks]
Change in subject resiliency scores measured by the Connor-Davidson Resilience Scale (CD-RISC 2)

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Individuals ≥ 18 years of age.
Current inpatient at the Mayo Clinic Health System Bloomer Hospital, Bloomer, Wisconsin (a Swing Bed Hospital as defined by the Center for Medicare and Medicaid Services (CMS)).
Able to speak English.
Able to answer questionnaires.

Exclusion Criteria:

Individuals < 18 years of age.
Patient unwilling or unable to provide consent to participate in this research study.
Patient under guardianship.
As determined through self-report, patient in active psychosis, active suicidal ideation, active substance abuse meeting criteria for substance use disorders except for nicotine (the exception is patients with a history of substance abuse that have been in remission for at least one full year).
Patient diagnosed with obsessive-compulsive disorder, active panic disorder with agoraphobia or other phobic disorder, active Post Traumatic Stress Disorder, or active severe personality disorders.
Patient with previous participation in this study.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Mayo Clinic Health System Bloomer Hospital	Bloomer	Wisconsin	United States	54724

Sponsors and Collaborators

Mayo Clinic

Investigators

Principal Investigator: Lori M Miller, MAOM, RN, Mayo Clinic

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Mayo Clinic Clinical Trials

Publications

None provided.

Responsible Party:

Lori M. Miller, Principal Investigator, Mayo Clinic

ClinicalTrials.gov Identifier:

NCT04970641

Other Study ID Numbers:

21-003878

First Posted:

Jul 21, 2021

Last Update Posted:

Feb 24, 2022

Last Verified:

Feb 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Study Results

No Results Posted as of Feb 24, 2022